Clinical Trial Update: Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating lenalidomide plus azacitidine versus azacitidine alone in myelodysplastic syndromes with ring sideroblasts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Myelodysplastic Syndromes | Phase 4 | Status: UNKNOWN